Efficacy and Safety of Aerosolized Intra-tracheal Dornase Alpha Administration in Patients With COVID19-induced ARDS (COVIDORNASE)

Conditions:   COVID-19;   Acute Respiratory Distress Syndrome Interventions:   Drug: Dornase Alfa Inhalation Solution [Pulmozyme];   Procedure: standard procedure Sponsors:   Fondation Ophtalmologique Adolphe de Rothschild;   University Hospital, Strasbourg, France Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials